Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
- 31 May 2005
- Vol. 23 (29) , 3864-3874
- https://doi.org/10.1016/j.vaccine.2004.10.032
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting DosesJournal of Investigative Dermatology, 2001
- Calreticulin, a component of the endoplasmic reticulum and of cytotoxic lymphocyte granules, regulates perforin-mediated lysis in the hemolytic model systemBiochemistry and Cell Biology, 1998
- Interaction between a Ca2+-Binding Protein Calreticulin and Perforin, a Component of the Cytotoxic T-Cell GranulesBiochemistry, 1998
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- Oligosaccharide Binding Characteristics of the Molecular Chaperones Calnexin and CalreticulinBiochemistry, 1998
- Calreticulin, a multifunctional Ca2+ binding chaperone of the endoplasmic reticulumBiochemistry and Cell Biology, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAPImmunity, 1996
- Tumor Antigens Recognized by T LymphocytesAnnual Review of Immunology, 1994
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993